Cargando…
Management of Advanced Invasive Melanoma: New Strategies
The incidence of cutaneous melanoma (CM) is increasing. CM is defined as melanoma in situ when limited within the epidermis and invasive when atypical melanocytes progressively invade the dermis. Treatment of CM is challenging. On one hand, melanoma in situ does not require further treatment except...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329960/ https://www.ncbi.nlm.nih.gov/pubmed/37306810 http://dx.doi.org/10.1007/s12325-023-02555-5 |
_version_ | 1785070128335945728 |
---|---|
author | Villani, Alessia Scalvenzi, Massimiliano Micali, Giuseppe Lacarrubba, Francesco Fornaro, Luigi Martora, Fabrizio Potestio, Luca |
author_facet | Villani, Alessia Scalvenzi, Massimiliano Micali, Giuseppe Lacarrubba, Francesco Fornaro, Luigi Martora, Fabrizio Potestio, Luca |
author_sort | Villani, Alessia |
collection | PubMed |
description | The incidence of cutaneous melanoma (CM) is increasing. CM is defined as melanoma in situ when limited within the epidermis and invasive when atypical melanocytes progressively invade the dermis. Treatment of CM is challenging. On one hand, melanoma in situ does not require further treatment except for a limited secondary excision with reduced margins to minimize the risk of local recurrences; on the other, invasive melanoma requires a personalized approach based on tumor staging. Consequently, an association of surgical and medical treatments is often necessary for invasive forms of the disease. In this scenario, new knowledge on melanoma pathogenesis has led to the development of safe and effective treatments, and several drugs are currently under investigation. However, extensive knowledge is required to offer patients a tailored-tail approach. The aim of our article was to review current literature to provide an overview of treatment options for invasive melanoma, highlighting strategical approaches that can be used in patients with these forms of disease. |
format | Online Article Text |
id | pubmed-10329960 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-103299602023-07-11 Management of Advanced Invasive Melanoma: New Strategies Villani, Alessia Scalvenzi, Massimiliano Micali, Giuseppe Lacarrubba, Francesco Fornaro, Luigi Martora, Fabrizio Potestio, Luca Adv Ther Review The incidence of cutaneous melanoma (CM) is increasing. CM is defined as melanoma in situ when limited within the epidermis and invasive when atypical melanocytes progressively invade the dermis. Treatment of CM is challenging. On one hand, melanoma in situ does not require further treatment except for a limited secondary excision with reduced margins to minimize the risk of local recurrences; on the other, invasive melanoma requires a personalized approach based on tumor staging. Consequently, an association of surgical and medical treatments is often necessary for invasive forms of the disease. In this scenario, new knowledge on melanoma pathogenesis has led to the development of safe and effective treatments, and several drugs are currently under investigation. However, extensive knowledge is required to offer patients a tailored-tail approach. The aim of our article was to review current literature to provide an overview of treatment options for invasive melanoma, highlighting strategical approaches that can be used in patients with these forms of disease. Springer Healthcare 2023-06-12 2023 /pmc/articles/PMC10329960/ /pubmed/37306810 http://dx.doi.org/10.1007/s12325-023-02555-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Review Villani, Alessia Scalvenzi, Massimiliano Micali, Giuseppe Lacarrubba, Francesco Fornaro, Luigi Martora, Fabrizio Potestio, Luca Management of Advanced Invasive Melanoma: New Strategies |
title | Management of Advanced Invasive Melanoma: New Strategies |
title_full | Management of Advanced Invasive Melanoma: New Strategies |
title_fullStr | Management of Advanced Invasive Melanoma: New Strategies |
title_full_unstemmed | Management of Advanced Invasive Melanoma: New Strategies |
title_short | Management of Advanced Invasive Melanoma: New Strategies |
title_sort | management of advanced invasive melanoma: new strategies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329960/ https://www.ncbi.nlm.nih.gov/pubmed/37306810 http://dx.doi.org/10.1007/s12325-023-02555-5 |
work_keys_str_mv | AT villanialessia managementofadvancedinvasivemelanomanewstrategies AT scalvenzimassimiliano managementofadvancedinvasivemelanomanewstrategies AT micaligiuseppe managementofadvancedinvasivemelanomanewstrategies AT lacarrubbafrancesco managementofadvancedinvasivemelanomanewstrategies AT fornaroluigi managementofadvancedinvasivemelanomanewstrategies AT martorafabrizio managementofadvancedinvasivemelanomanewstrategies AT potestioluca managementofadvancedinvasivemelanomanewstrategies |